openPR Logo

Press Releases from Tardive Dyskinesia Therapeutics- Pharma Proff (1 total)

Tardive Dyskinesia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Resul …

Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs which are prescribed to treat certain psychiatric or gastrointestinal conditions. Long-term use of these drugs may produce biochemical abnormalities in the area of the brain known as the striatum. Download the sample report @ The reasons that some people who take these drugs may get TD, and some people do not, is

Go To Page:   1 2 3 4 5 6 7 8 9 10